PSUSA/00010465/202512 - periodic safety update report single assessment
allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)
PSUSAHuman
Slovenian is available via eTranslation, the European Commission's machine translation service.
Translate to Slovenian | Important information about machine translation
O modulu
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)
- Procedure number
- PSUSA/00010465/202512
- Regulatory outcome
- Maintenance